EGCG can inhibit the stemness of CRC cells by downregulating the expression of biomarkers such as CD133, CD44, NANOG, OCT4, ALDH1 and Wnt/β-catenin signaling pathway [76,77]. This evidence concerns the gene ALDH1A1 and colorectal carcinoma.